Analyst Notes

First-person thesis from the lead analyst. Read this before the data tabs. Analyst View

What the market bought. In August, investors bid ₹61,073 cr for a ₹700 cr issue: about 117.6x overall, with QIBs at about 221x, NIIs at ~176x and retail at ~38.5x. They were buying a simple story. This is a 24.6%-RoE conductor-and-EPC company riding India's transmission capex cycle, offered at 15.6x post-issue FY26 earnings when KEC traded near 20x, Kalpataru near 22x and Apar near 69–78x. Twelve brokers said Subscribe and nobody said Avoid. One month later the stock is ₹98.6, still 20% above issue but 19% off its ₹122 high. That is despite a clean Q1 (revenue +19.3%, EBITDA margin 13.6%, PAT +32.4%) and a CRISIL upgrade to A+. At 17.7x trailing earnings the stock still looks cheap. I don't think it is as cheap as it looks.

The profits are not turning into cash. Over FY24–26, Lumino reported ₹371 cr of PAT and generated ₹18 cr of operating cash flow, a 5% conversion rate. Even that ₹18 cr depends on accounting choices. In FY26 the company voluntarily reclassified its supplier-finance obligations (TReDS, vendor bill discounting and LC-backed usance acceptances) out of "Borrowings" and into a separate "Trade Acceptances" line (RHP Note 29.1). It moved their cash settlements from financing to operating activities and restated prior years. The ₹387 cr of acceptance inflows over three years now sits inside OCF. Strip it out and three-year OCF is −₹369 cr. FY26's headline ₹156 cr OCF was ₹4.8 cr before acceptances. The cash went into receivables, which rose ₹435 cr in two years to ₹895 cr (160 days), into inventory, which doubled to ₹364 cr, and into ₹309 cr of retention money. CRISIL also counts ₹228 cr of debtors older than six months. This is the single most important fact in the file.

Leverage is somewhere in between the bull and bear headlines. The bear pitch says borrowings went from ₹384 cr to ₹1,856.78 cr by July 2026, about 7.8x EBITDA. That is wrong. About ₹923 cr of the total is bank guarantees, which are contingent EPC performance and advance guarantees. The "0.53x D/E" bull figure is also wrong. Per RHP Note 29.2 the LCs are supplier-finance acceptances on the balance sheet. So the debt-like total is about ₹934 cr: ₹319 cr of bank debt plus ₹615 cr of LC acceptances and discounting. After the ₹337 cr IPO prepayment that leaves ~₹597 cr, or about 2.5x FY26 EBITDA Est.. At FY26, D/E including acceptances and leases was 1.37x. Lumino is not over-levered after the IPO. But it is a working-capital-financing business wearing a light balance-sheet presentation.

Growth and earnings quality are weaker than the headlines. FY26 revenue grew 6.4%, after +36% and +85%, in the year right before the IPO. Underlying EBITDA was flat: FY25 carried a ₹17.65 cr entry-tax provision, so adjusted FY25 EBITDA was ~₹240.6 cr against FY26's ₹238.95 cr. FY26 also booked a ₹11.7 cr entry-tax write-back on an undisclosed P&L line. If that sits inside EBITDA, the underlying trend is weaker still Analyst View. FY26 PAT growth of 28% came from other income (₹48 cr, 24% of PBT) and tax credits (~₹19 cr of deferred and prior-year credits). Order inflow is now the problem I watch most. Q1 FY27 inflow was ₹176 cr against ₹521 cr of revenue, a 0.34x book-to-bill. The order book fell QoQ to ₹3,059 cr, the manufacturing backlog fell ~10%, and FY26's bid-win ratio dropped to 14.4%. Q1's growth was EPC (+69.6%). Manufacturing, 71% of revenue, grew 6.5% against the 25–30% CAGR management is guiding to.

Governance is the part that worries me most. MD Devendra Goel has personally guaranteed about ₹1,612 cr of working-capital lines across 13 banks for Laser Power & Infra. Laser is his brother Deepak Goel's listed competitor, carved out of Lumino in the 2021 demerger and listed July 2026. Deepak Goel in turn guarantees Lumino's lines. The MD's disclosed net worth is ₹24.6 cr, so this exposure is about 65x it. The RHP nonetheless says the promoters have no venture in the same line of business. Separately, P.S. Enterprise, a partnership of the founder and the MD's wife, was the No. 1 raw-material supplier in FY24–25 (₹270 cr of purchases in FY25, ₹175 cr in FY26, ₹21.4 cr of advances outstanding). Add the income-tax search of 15–16 March 2022, a dormant ROC complaint alleging corrupt practices in a Punjab HTLS tender, 19 company-filed criminal complaints about site pilferage, CARO stock-statement mismatches, and a complete pre-IPO change of independent directors, CFO, CS and auditors. This needs a governance discount, not a peer premium. The SEBI observation-letter timing is a separate open question, not an irregularity finding: the letter was dated 9 Jun 2025 and the issue opened ~14.5 months later, with no extension cited.

What tempers the caution. The IPO did fix the funding side. ₹337 cr of debt is gone, CRISIL is at A+ with 0.20–0.30x expected gearing, and funding costs only about 7%. The mix shift is real: aluminium conductors are +54.6%, EHV substations went from zero to ₹91 cr of revenue and 44.6% of the EPC backlog, and the customer base has broadened (top-10 down from 90.8% to 46.5%). The sector tailwinds are concrete: RDSS extended to Mar-2028, GEC-III and NEP-Transmission at ₹9.15 lakh cr. If H1 FY27 shows debtor days falling and inflow back above 1x revenue, the 17.7x multiple will look cheap in hindsight.

Near-term technicals and my stance. The remaining 1.26 cr anchor shares (~4.1% of equity, ~₹125 cr) unlock on 30 Nov 2026, and the BRLM research arms start coverage after mid-October. My stance is Neutral with a cautious tilt. I would not chase the IPO-discount argument. Re-engage on (1) H1 FY27 OCF excluding acceptances turning positive, (2) two quarters of book-to-bill above 1x, and (3) disclosure of how the Laser guarantees are being run down. Valuation work should start from the adjusted ~13.5x EV/EBITDA, not the 11x headline.

Business Deep-Dive

Source: RHP 20 Aug 2026 (Our Business pp.246–279), company website, CRISIL. ₹ cr unless stated.

History and corporate timeline

Manufacturing products (FY26: ₹1,423.45 cr, 69.74%)

EPC businesses (FY26: ₹617.63 cr, 30.26%)

Facilities

Ranihati project cost: governance file cites ~₹190 cr budget; business/narrative files and CRISIL say cost and funding mix are not disclosed. Treat ₹190 cr as unverified. The two existing units total 264,208 sq ft, all in one district (RHP flags the concentration).

Capacity and utilisation

Roadmap: Unit I debottlenecking +10,980 MT (₹15.01 cr IPO capex, FY27–28) to 50,980 MT. Ranihati Phase 1 +10,000 MT H2 FY27, Phase 2 +11,000 MT Q3 FY28, Phase 3 +14,000 MT Q1 FY29 → 75,000 MT. Whether the Unit I addition is inside the 75,000 MT is not reconciled. Management guides ~₹200 cr extra revenue.

Process, technology, certifications, IP

Exports

17 countries; 26 states + 4 UTs. Export customers: utilities in USA, Mali, Burkina Faso, Côte d'Ivoire, Ghana, Nepal, Bangladesh, Kenya, Rwanda, Ethiopia, Niger. Overseas order book Mar-26: Mfg ₹69.1 cr (5.97%), EPC ₹3.5 cr (0.17%). USD receivables $1.30 mn, 85% hedged. The website MD note mentions possible ventures into roads/highways and oil/piped-gas distribution; this is not in the RHP. Analyst View unrelated diversification risk.

Segment Analysis

Ind AS 108 note 45.13 (RHP p.376). Segment basis changed in FY26 with restated comparatives. ₹ cr.

Segment results

Segment results sum to ₹270.8 cr in FY26, ~₹48 cr above operating EBITDA less D&A (~₹222.5 cr). Other income, and possibly the entry-tax write-back, appear to be allocated into segments, so treat segment EBITDA as an upper bound.

Product and business-line growth

Management focus: use new capacity for "specialised conductors and cables, including products for higher-voltage applications". In EPC, target substations and HTLS reconductoring "where product manufacturing and project execution capabilities can be deployed synergistically" (Devendra Goel, Sep 2026). Guidance: EPC >30% growth, manufacturing "double-digit".

Financials: P&L

RHP restated consolidated FY24–26 (p.91), tie-checked. FY22–23 from Screener (unverified basis). ₹ cr.

RHP KPI "PAT margin 7.66%" is PAT ÷ total income. Some portals (Bajaj Broking, IPOWatch) mislabel total income as revenue.

Five-year view

*Screener. CRISIL FY22 revenue 604.85 / PAT 39.35; FY23 760.26 / PAT 20.77. Screener's FY24–26 EBITDA (157/233/253) and interest (48/77/80) move ~₹12–14 cr/yr of bank charges out of opex. CAGRs: FY22–26 revenue ~35.9%; FY24–26 revenue 20.4%, PAT 35.9%.

Quarterly results (only 3 quarters public)

ND = not disclosed. Derived Q2+Q3 FY26 (Screener basis): revenue ~₹891 cr, EBITDA ~₹110 cr, PAT ~₹64 cr. Q4 FY26 carried 35% of FY26 revenue and 41% of PAT. Q1 FY27 still consolidates RJ Green (deconsolidated 7 Aug 2026). Sahi's "₹4.03 cr profit" headline is a 10x unit error; the correct figure is ₹40.17 cr.

Earnings-quality check

Financials: Balance Sheet, Cash Flow & Ratios

RHP restated consolidated (pp.90–94, 413–420) plus lead-analyst rulings on RHP Note 29/29.1/29.2. ₹ cr.

Balance sheet

FY24 "₹40.91 cr borrowings" is correct (balance-sheet line); the separate ₹401.36 cr of trade acceptances explains the apparent "10x debt jump". Screener's debt series is inconsistent (FY24 458 includes acceptances; FY25–26 438/401 exclude). Equity capital rose 30→122 from the Nov-2024 3:1 bonus. Retention money ₹308.73 cr FY26; CRISIL puts retention + unbilled at ~₹474 cr.

Five-year summary and adjusted debt

*Screener; FY22–23 borrowings likely include acceptances (unverified). FD encumbrance [RHP p.419]: of ~₹186.11 cr FDs, ₹33.07 cr pari-passu lien + ₹140.53 cr pledged as LC/BG margin = ~₹173.6 cr encumbered.

Cash flow (RHP restated)

Screener's FY24 OCF of −92 = RHP 100.91 less the 193.08 acceptance inflow, i.e. Screener reclassified acceptances to financing for FY24 only. RHP figures are authoritative (mStock's +100.9 matches the RHP).

Working capital

Other bases: RHP NWC ₹716.72 cr (35.11% of revenue, from 16.09% in FY24), "working capital cycle" 86 days. RHP business section quotes debtor days 145 and inventory 56 days (different denominator; debtor days rose from 92). CRISIL (Mar-26): inventory 74 days, retention-adjusted receivables 132 days, GCA expected 250–275 days. This report uses 160 debtor days elsewhere. The operating cycle (receivables + inventory) went from ~209 to ~280 days over FY24–26, funded by supplier-side discounting.

Ratios

†Screener-based. Implied cost of funds ~7.0% (₹66 cr on ~₹939 cr average adjusted debt), consistent with RHP rates; Screener's "high cost of borrowing" flag is an artefact of excluding acceptances. Pro forma post-IPO RoE ~13.4% on ~₹1,193 cr equity [Est.].

Financial indebtedness at 31 Jul 2026 (RHP p.418, ₹ mn)

* LC/BG interchangeable; ^ refer Note 29/29.1 (trade acceptances); ** TReDS not bank-sanctioned. Certified jointly by Singhi & Co. and SDP & Associates, 20 Aug 2026.

Lead-analyst split of the ₹1,856.78 cr (RHP Note 29.2 ruling)

Key terms [RHP pp.419–420]: secured tenor 3 months–6 years 2 months, unsecured 3 months–1 year. Rates: secured 7.50–9.25%, vehicle 9.00%, unsecured 6.25–9.25% (repo/MCLR + spread). Security includes: first pari-passu charge on current assets and P&M; mortgage of Jangalpur factory land (~120.3 decimals owned by MD Devendra Goel personally, 287.6 decimals by the company); mortgage of office units 12/4 and 12/3 owned by DRP Realtors and Brijdham Infrastructure (also corporate guarantors); personal guarantees of Deepak Goel, Devendra Goel and Jay Goel; FD liens. Prepayment and penal interest each up to 2%. Covenants require lender consent for capital-structure changes, promoter dilution below a threshold, new projects and additional charges. Tofler's "no charges registered" is wrong. Capitalisation Mar-26 [p.417]: current ₹350.71 cr, non-current ₹33.45 cr, total ₹384.17 cr; borrowings/equity 0.53x; non-current/equity 0.05x.

CRISIL-rated facilities (₹2,000 cr, 2 Jul 2026) and lenders

Punjab & Sind Bank was a lender in Feb-2024 but not in Jul-2026. RHP sanctioned limits (₹2,158.68 cr) exceed CRISIL's ₹2,000 cr mainly because vendor bill discounting is not bank-rated. Term-debt repayment ~₹21 cr/yr (vs ~₹9 cr in Feb-2024). No lender-wise maturity ladder is disclosed. Fund-based utilisation averaged ~52% (12 months to Mar-26; ~27% in 2023). Expected accruals ₹180–200 cr/yr. IPO prepayment targets HDFC, Union Bank, BoB, SBI, YES and IDFC First lines.

Credit ratings

CRISIL triggers. Upgrade: TOL/TNW ~1.5x and no large debt-funded capex. Downgrade: accruals below ₹40 cr, or debt-funded capex/acquisitions. Contingent liabilities Mar-26: ₹24.86 cr (claims ₹0.94 cr per financials file vs ₹1.03 cr per narrative file, a source conflict; tax ~₹23.9 cr incl. GST ₹14.36 cr, customs ₹9.47 cr; WBGST/CGST under appeal). The ~₹923 cr of outstanding BGs is not in this table. The DRHP figure was ₹25.9 cr at Sep-24.

Equity dilution and share-count history (RHP pp.113–124)

No cash dilution between FY22 and the IPO. No pre-IPO placement (the DRHP allowed up to ₹120 cr); claims of a "9:1 bonus" or an "₹343 placement" are false. IPO dilution 20.0%; promoters 100% → 71.97% (IPOWatch's "~80%" is wrong). No ESOP scheme, warrants, QIP or preferential allotments. Securities premium Nil pre-offer. Authorised capital ₹187 cr (35 cr equity + 2.4 cr preference shares of ₹5).

Management, Promoters & Governance

RHP pp.114–134, 286–292, 313–326, 370–374, 427–445; FY25 AR; lead-analyst rulings §3.

Promoters

Promoter group: Rashmi Goel (Devendra's wife; WTD until 2019; Lumicab LLP partner) 9.26% → 7.40%; RAG Private Family Trust 5.75% → 4.60%; Rohit Goel 1,336 sh; Devendra/Jay/Rohit family trusts 80,000 sh each. P.D. Goel HUF (7.46% at Mar-24) was dissolved 2 Sep 2024. Pre-IPO split: promoters 84.90%, promoter group 15.10%. Stakes were built mainly by intra-family gifts: Rashmi 17.9 lakh (Jul-2023); Deepak Goel 3,18,333 sh (12 Nov 2024); P.D. Goel 21.7 lakh (14 Nov 2024). Disassociations in the last 3 years: Lumino Bio Fuel and Shree Krishna Bio Fuel Energy (struck off), Unique Heights and Akshat Builders (ceased), Screenzy Digital Commercial (struck off 2025–26).

Key management

KMP pay: ₹11.07 cr in FY24 (12.8% of PAT), ₹8.86 cr in FY25 (~7%). Family salaries: Rashmi Goel ₹2.21 cr FY24; Rohit Goel ₹21.6 lakh FY25. No ESOPs.

Board (Aug 2026): 6 members, 50% independent

The full ID slate was replaced in Dec 2024, a month before the DRHP (Hari Ram Agarwal, Kanchan Jalan and Priti Agarwal ceased 19–20 Dec 2024). Tenure of all IDs is under 2 years. Committees (FY25 AR): Audit = Sultania (Chair), Bhandari, Devendra Goel (MD). NRC = Sultania, P.D. Goel, Mathur. SRC = P.D. Goel (Chair; attended 0 of 1), Devendra Goel, Sultania. RMC and CSR are chaired by Devendra Goel. Executive and IPO committees exist. 18 board and 9 audit committee meetings in FY25.

Shareholding

A four-quarter trend does not exist (listed Sep-2026). Pledge: nil (RHP p.134; aggregators post-listing). Insider/SAST: none up to 6 Oct 2026. The only promoter sale was the ₹200 cr OFS at near-zero cost basis.

Laser Power & Infra cross-guarantees (RHP Risk Factor 24; ruling §3)

Related-party transactions

PSE purchases needed board approval (27 Mar 2025) and an EGM approval (16 May 2025; ₹240 cr ex-GST limit). PSE remains ~8.6% of revenue, yet the RHP says there is "no conflict of interest between the suppliers … and our Promoters" (p.317). Equity held in DRP Realtors (₹1.9 cr) and Shanti Infrabuild (₹0.11 cr). Jagannath Concrete Poles is also a counterparty (purchases, advances). New FY26 related parties: LIL-PCSCPL-JV, Hemant Bhuwania, Vivek Jain. FY26 RPT columns were scrambled in extraction; only reconciling figures are shown.

Auditors and controls

• Joint statutory auditors: SDP & Associates (FRN 322176E; Pranita Dalmia; sole auditor to FY24) and Singhi & Co. (FRN 302049E; Navindra Kumar Surana; appointed 30 Sep 2024 AGM for 5 yrs).
• SDP lacked an ICAI peer-review certificate, so Singhi re-audited FY24 for the IPO (RHP p.324).
• Opinions: FY25 unmodified (15 May 2025); FY26 unmodified (5 Jun 2026); no qualifications in restated financials. Other Matters: Rwanda branch (assets ₹1.6 cr, revenue ₹2.2 cr) and four subsidiaries audited by others.
• CARO FY25: stock statements to banks differed from books (₹13.5 cr Q4 FY25; up to ₹30 cr/quarter in FY24); frauds ₹93.48 lakh; disputed dues. Audit trail not enabled at database level (Rule 11(g)). FY26 CARO not yet published.
• Changes: secretarial auditor Payal Goenka → Hansraj Jaria; internal auditor Amit Kumar Baheti → EY LLP. Tax-litigation certificate by V Jalan & Co.

Subsidiaries, JVs and group structure

Subsidiaries are immaterial (FY26 assets ₹0.67 mn, revenue nil); the parent is ~100% of net assets and PAT. There are no operating acquisitions. Group companies (6, all at Unit 6/11 Merlin Acropolis): Brijdham Infrastructure, DRP Realtors, Lumino Finvest, Lumino Power Infrastructure, Shanti Health Services, Shanti Infrabuild. Promoter-group entities with same-line or adjacent names: Laser Power and Infra, Klarix Wires LLP, Ganpati Transmission and Power, Ganpati Electricals, Sanjay Casting, SCE Infratech, UIC Udyog, Jagannath Concrete Poles, Lumicab LLP, Laser Developers, SRS Tractors. Analyst View Ganpati Electricals and UIC Udyog share names with an FY24 top-10 customer and an FY24–25 top-10 supplier; we infer they are the same entities, but the RHP does not say so. 2021 scheme transferors (14): Adishwar Trade Link, Astra Vinimay, Barden Agencies, DRP Trading, Embassy Vyapaar, Jalsagar Sales, JBLD Trading, Kasauti Dealtrade, Lumino Electrical Industries, Lifeline Commotrade, Sanatan Vinimay, Regal Financial Advisory, Sigma Vyapaar, Welkon Goods (board approval 30 Sep 2020; valuer Astha Gupta, NAV method).

Litigation, tax, regulatory

No SEBI/exchange actions against promoters; no IBC; not a wilful defaulter; no criminal matters against KMP or subsidiaries. The DRHP mentioned an NI Act s.138 complaint against the company and a civil writ; the RHP lists no criminal proceedings against the company. ThePrint's Aug-2022 I-T raid on a Kolkata T&D group is not attributed to Lumino.

Supply Chain

RHP pp.29–39, 263–279; CRISIL. ₹ cr.

↑ Upstream: what Lumino depends on

Materials + inventory change + erection/subcontracting = 83.73% of total expenses in FY26 (82.44% FY25, 83.40% FY24). RM/WIP inventory is held 39–56 days. CRISIL: copper and aluminium are 75–80% of raw-material cost.

• BALCO (Vedanta) and Hindalco are named aluminium/copper sources; NALCO is not named. Roles of Kritika/Nirmal (likely steel/GI core wire) and Maruti Recycling/Asier (likely secondary metal) are analyst inference.
• 68 suppliers on short-term contracts, 2 on annual contracts; pricing is LME-linked spot. Import share and source countries are not quantified ("a certain portion" imported; customs dispute confirms imports). Middle-East freight and Red Sea costs hit the Rwanda project.
• EPC bought-outs (transformers, switchgear, GI structures, towers, insulators, SCADA, solar modules) and subcontracted erection vendors are unnamed. Vendors are paid via TReDS reverse factoring (trade acceptances ₹595.47 cr).
• Pass-through: price-variation clauses in "most" contracts, plus hedging and inventory. CRISIL (2024) says "not all contracts have embedded price escalation clauses"; some fixed-price EPC contracts have none, and escalation claims are lost when procurement is delayed. FY26 manufacturing revenue rose 14% on 4% lower volume. Lumino is a price-taker passing metal costs through with a lag.

↓ Downstream: who depends on Lumino

Other named customers. Conductors/cables: Kalpataru, Jakson, Warora Kurnool Transmission, WRSS XXI(A) Transco, Monte Carlo, R.S. Infraprojects, K.G.N. Electricals, UGVCL; historically (CRISIL) PGCIL, L&T, Tata Projects, NCC, NBPDCL/SBPDCL; narrative sources also cite NTPC, KEC and RDSO. EPC: WBSEDCL, KPDCL, APDCL/AEGCL, PuVVNL, RVPN, AVVNL, PGVCL, UGVCL, JBVNL, JUSNL, SBPDCL/NBPDCL, KSEB, Ircon, KMDA, UP Jal Nigam, WB PHED, Rwanda Energy Group. Who replaced the government volume in FY26 is not explained.

Contract terms: EPC 24–30 months (CRISIL 1.5–2 yrs). Payment 60% of supply within 30 days, 30% on installation, 10% on commissioning, plus retention (₹308.7 cr). O&M tails of 3 yrs (solar), 10 yrs (UPJN) and 15 yrs (Katwa STP). Product orders are L1 tenders, so stickiness is low. The moat is pre-qualification: PGCIL Grade A, type tests, UL, 44 substations and 80,000 ckm. End-products: 11–400 kV lines, HTLS corridors, LT ABC networks, substations, rail signalling and 25 kV OHE, solar plants, building wiring, UL wire into US buildings.

Value-chain map

Competitive Position

Screener consolidated, 6 Oct 2026; ratios recomputed. Peer table uses Screener EBITDA basis for comparability (Lumino 253 / 12.4%; RHP basis is 238.95 / 11.71%).

*Techno PAT% inflated by ₹175 cr treasury income. EV = mcap + borrowings − investments (cash in other assets not netted). RHP peer set: KEC 19.81x, Kalpataru 22.13x, Apar 68.98x; range 19.81–108.66x, average 48.55x; industry P/E 23.04x (Groww). Revenue comparisons: Bajel ₹2,818.6 cr, Universal Cables ₹3,051.0 cr, Techno ₹3,401.2 cr. FY26 RoE 24.62% was the highest in the RHP set and 11.71% EBITDA beat 6 of 7 peers (IPO Central/BusinessToday).

Market position and share [Est.]

• Conductors: ₹735 cr vs CRISIL market ₹22,700 cr = ~3.2% share. Apar is #1; others are Sterlite/Resonia, Gupta Power, JSK, Laser, Diamond, Transrail, Hindusthan Urban, Cabcon. No published rank for Lumino.
• Wires & cables: ₹634 cr vs ₹1,61,800 cr = ~0.4%. Leaders are Polycab, KEI, Havells, Finolex, RR Kabel, Apar.
• T&D EPC: ₹618 cr, a small regional player. In substations it competes with Techno, Bajel, Siemens, Hitachi Energy, GE Vernova and regional contractors. Lumino is the smallest listed peer.
• CRISIL-in-RHP claims (company-commissioned): FY22–24 revenue CAGR above every peer; FY24 PAT margin 6.07%, RoE 21.52%, EBITDA 10.14% "among the higher". These are FY22–24 claims; FY26 growth lags.

Industry size and trends

Trends: (1) an RE-evacuation transmission super-cycle (500 GW non-fossil by 2030, GEC-III, ISTS) skewed to 400/765 kV and HVDC, where Lumino's sub-400 kV credentials matter less; (2) HTLS reconductoring (CEA Regulations 2025 Schedule VII; RTM route favours incumbent TSPs). CTC also licenses Apar, Sterlite, Gupta and JSK, so the CTC tie-up gives Lumino no exclusivity; (3) RDSS extended, back-ended; (4) export/China+1, where Lumino is under-indexed; (5) commodity pass-through; (6) an IPO wave adding capacity (Transrail Dec-2024, Laser Jul-2026, Lumino Sep-2026, SME names).

Policy

Pricing power: weak. Moat: narrow. The 2.5% (FY23) → 7.8% (FY26) PAT margin expansion coincided with the pre-IPO period, a mix shift and rising other income. Integration is weakening (captive 65% → 23%).

Strengths and weaknesses vs peers

Risks & Red Flags

Merged from market, financials, governance and rulings. Superseded input claims have been corrected (OCF, litigation, auditor, RPT).

Red-flag checklist

Risk register

Commentary, Guidance & Street Sentiment

No concall transcripts exist. The company listed 3 Sep 2026, and Q1 FY27 (21 Sep 2026) came via press release only. This tab therefore uses management statements, CRISIL-recorded projections, IPO-street data and sentiment.

Quarter log

Management in its own words

• Devendra Goel (Q1 FY27): "The strategic priority will be to use the additional capacity to increase the contribution from specialised conductors and cables, including products for higher-voltage applications."
• On EPC: "the company will focus on opportunities across substations and HTLS reconductoring, where its product manufacturing and project execution capabilities can be deployed synergistically."
• BusinessLine (Aug 2026): "So there is a unique integration between the product that we manufacture and the EPCs that we do."
• Guidance (Sahi, 23 Sep 2026; possibly paraphrase): revenue CAGR 25–30%, EPC >30%, manufacturing double-digit; ~₹200 cr revenue from new capacity; 40k → 75k MT by Q1 FY29.

Tone: confident and promotional ("fastest-growing integrated power EPC"). Recurring themes: integration (captive 23% in FY26 vs DRHP-era 62.38%), moving up to EHV/HTLS, deleveraging, Ranihati. The FY26 slowdown was not explained. CRISIL's 2 Jul 2026 rationale records that the company appealed the A reaffirmation before the post-IPO upgrade.

Guidance vs actual (credibility)

IPO structure: DRHP vs final

Timeline: DRHP 20 Jan 2025 (board authorisation 9 Dec 2024) → BSE/NSE in-principle 20 Mar 2025 → SEBI observation 9 Jun 2025 (reported 17 Jun) → DRHP corrigendum (board 28 Jul 2026; SEBI site ~19 Aug) → RHP 20 Aug 2026 (selling-shareholder consent 8 Aug) → anchor 25 Aug → issue 27–31 Aug → allotment 1 Sep (1,67,531 allottees) → listing 3 Sep. Price band ₹78–82; lot 182 (₹14,924). Registrar Bigshare. BRLMs Motilal Oswal, JM Financial, Monarch Networth.

Subscription

Other circulating figures: 118.12x (Upstox/India TV), 117.78x (BS), 104.31x (Kotak 4:45 pm snapshot), 87.25x (Chittorgarh; ₹61,073.49 cr bids ÷ ₹700 cr including anchor; 57.31 lakh applications), 58.19x and ~50x (intraday snapshots / category-weighted on stale QIB data). ₹61,073 cr ÷ ₹493 cr non-anchor ≈ 124x. Day 1 was 0.98x. Differences come from denominators and snapshot times.

Grey market premium

Listing at ₹110 NSE (+34.15%) / ₹109 BSE (+32.9%) was ~₹10 below the last GMP, which led to "misses GMP" headlines. InvestorGain classed it a "negative listing for GMP".

Anchor book (25 Aug 2026): ₹207 cr, 30 investors, 2,52,43,901 shares

Domestic MFs took 71.59% (1,80,71,114 sh; 22 schemes; HDFC, Kotak, Motilal Oswal, Bandhan, Edelweiss, JM Financial, Bank of India). Life insurers 6.74%. Others: SBI General, Bajaj Life, Kotak Life, 3PIM India Equity (IFSC), Silver Stride, Ashika Global, HDFC Large & Mid Cap, Motilal Oswal Large Cap. House totals: Kotak ₹44.95 cr, HDFC ₹44.93 cr, Bandhan ₹19.94 cr. Lock-ins: 1,26,21,951 shares freed 1 Oct 2026; 1,26,21,950 free on 30 Nov 2026 (~4.1% each; media "3.1%" and "15%" are wrong).

Brokerage IPO notes (no target prices)

Chittorgarh tally: 12 Subscribe, 1 May Apply, 0 Avoid (ipocentral/IPO Guru: "Strong Apply", 6 analysts). Post-listing coverage: none yet (Trendlyne: no estimates). BRLM research quiet period ends ~mid-Oct 2026.

Price, flows and media timeline

Media tone moved from positive (IPO) to "neutral with caveats" (listing GMP miss; NewsDrum/PTI), to positive (Q1, CRISIL; Outlook, TradeBrains, Sahi, Lapaas), to supply-negative (Mint/TradingView, Analytics Insight unlock lists). No ValuePickr or Reddit threads; X tipster posts only (@BaluGorade "124x, GMP 54%"). No on-record fund-manager commentary. Trendlyne tags "Expensive Valuation". Value Research names Kotak Special Opportunities 1.88% and HDFC Value 1.80% (unverified). QIBs were allotted ~13.8% and FII+DII hold 12.85%, so institutions largely held.

Growth, Outlook & Valuation

Order book

The Q1 bridge does not reconcile: 3,150 + 176 − 521 = 2,805 vs 3,059 reported, implying unexplained scope/escalation additions. (A narrative-file estimate of 0.83x is superseded.) EPC backlog ₹2,013 cr ≈ 3.3 years at the Q1 EPC run-rate; manufacturing backlog ≈ 2.8 quarters. CRISIL says Lumino is L1 on "a few orders" (value undisclosed). No exchange-disclosed order wins since listing. EPC order book by line: EHV substations 44.57% (~₹888 cr [Est.]); the rest mainly RDSS distribution, MVCC, solar and water.

Awards over the last three years include WBSEDCL RDSS (Bankura, Coochbehar, Kharagpur, Khatra, Purulia), JBVNL Deoghar, RVPN 220 kV GSS (Jawali, Sumerpur, Bayana, Bhanwata, Andhi, Deogarh), Udaipur 400/220 kV GSS, Kankani 400 kV bays (JPMIA/DMIC), SBPDCL Bhagalpur, NBPDCL Motihari/Begusarai, PuVVNL feeder segregation (Mau, Jaunpur, Fatehpur), PGVCL MVCC (Surendranagar, Anjar, Jamnagar), AVVNL Bhilwara, APDCL Pkg-37, AEGCL 132/33 kV, JUSNL Maithon 58 km, KSEB 220 kV GIS, UGVCL Patan, RGGVY Saharsa, and RDSS Kanpur zone. The RHP "consideration outstanding" column is not backlog.

Expansion and catalysts

Valuation

EV build [Est.]: borrowings 384.2 − 337 = 47.2 + leases 17.2 − unencumbered cash 130 = net cash ~65.7 (or ~191.7 adding ~₹126 cr undeployed IPO funds); TTM EBITDA ₹257.2 cr RHP basis. Adjusted adds ₹595.5 cr acceptances. Gross-cash basis: ~10.4–10.9x headline, ~12.7–13.2x adjusted. Mar-26 balances; Q1 movements undisclosed. Peers trade at 19.81–108.66x P/E (RHP set); the discount reflects WC intensity, aluminium-heavy mix and acceptance funding.

Final Verdict

Sources

Merged and de-duplicated from the financials, business, governance, narrative, market and street-sentiment inputs and the lead-analyst RHP rulings. All accessed 6 Oct 2026 unless noted. "(403)/(snippet)" = content from search snippet only.

Primary filings and company

Credit ratings

Financial databases and entity data

IPO portals, data and reviews

Brokerage notes and independent reviews

News, results, listing, flows

Industry, policy, commodity

Data conflicts resolved in this report

Not available after search: five of last eight quarters; lender-wise maturity ladder; import share; Ranihati cost (no verified figure; ~₹190 cr unverified); order book by named client; HTLS revenue; post-listing targets; 3-yr average multiples; FY26 AR/CARO; RJ Green consideration; full anchor scheme list; Kostak rates; exact dates of the pre-2019 ₹500 issue and buy-back.